---
figid: PMC3359746__SRCM2012-849456.001
figtitle: Several growth factor signals activate cell membrane receptor tyrosine kinases
  leading to activation of downstream interacting signal transduction pathways (PI3K/AKT,
  RAF/MAPK, and MTOR)
organisms:
- NA
pmcid: PMC3359746
filename: SRCM2012-849456.001.jpg
figlink: /pmc/articles/PMC3359746/figure/fig1/
number: F1
caption: Several growth factor signals activate cell membrane receptor tyrosine kinases
  leading to activation of downstream interacting signal transduction pathways (PI3K/AKT,
  RAF/MAPK, and MTOR). Within the RAF/MAPK pathway, activated receptors lead to SHC-mediated
  activation of RAS and propagation of signalling through RAF, MEK (a.k.a. MAP2K),
  and MAPK (a.k.a. ERK). Activated MAPK forward signals to the nucleus that regulate
  proliferation, differentiation, angiogenesis, and cell survival. A second essential
  signalling pathway is the PI3K/AKT pathway. PI3K catalyzes triple phosphorylation
  of phosphatidylinositol (PI) AKT in conjunction with its PDK1. AKT is a key molecular
  “node” acting as a master switch, which triggers multiple downstream signaling pathways
  including mTOR pathway activation. A key regulatory enzyme is PTEN that modulates
  PI3K and SHC phosphorylation. Activated AKT signals a number of mitogenic processes
  promoting proliferation and increased cell survival, antiapoptotic signals, and
  upregulation of cell-cycle proteins (cyclin D1 and CDK4).
papertitle: The Molecular Biology of Soft-Tissue Sarcomas and Current Trends in Therapy.
reftext: Jorge Quesada, et al. Sarcoma. 2012;2012:849456.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9473109
figid_alias: PMC3359746__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC3359746__F1
ndex: 8b8862b8-defb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3359746__SRCM2012-849456.001.html
  '@type': Dataset
  description: Several growth factor signals activate cell membrane receptor tyrosine
    kinases leading to activation of downstream interacting signal transduction pathways
    (PI3K/AKT, RAF/MAPK, and MTOR). Within the RAF/MAPK pathway, activated receptors
    lead to SHC-mediated activation of RAS and propagation of signalling through RAF,
    MEK (a.k.a. MAP2K), and MAPK (a.k.a. ERK). Activated MAPK forward signals to the
    nucleus that regulate proliferation, differentiation, angiogenesis, and cell survival.
    A second essential signalling pathway is the PI3K/AKT pathway. PI3K catalyzes
    triple phosphorylation of phosphatidylinositol (PI) AKT in conjunction with its
    PDK1. AKT is a key molecular “node” acting as a master switch, which triggers
    multiple downstream signaling pathways including mTOR pathway activation. A key
    regulatory enzyme is PTEN that modulates PI3K and SHC phosphorylation. Activated
    AKT signals a number of mitogenic processes promoting proliferation and increased
    cell survival, antiapoptotic signals, and upregulation of cell-cycle proteins
    (cyclin D1 and CDK4).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Akt
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - MKP-4
  - p38b
  - rl
  - Mtor
  - Tor
  - Sos
  - ras
  - Ras64B
  - Ras85D
  - she
  - drk
  - Pdk1
  - IRSp53
  - IleRS
  - chico
  - Pten
  - Dsor1
  - Mtk
  - gig
  - Tsc1
  - Rheb
  - sgg
  - cass
  - Debcl
  - Thor
  - S6k
  - RpS6
  - eIF4E1
  - CAP
  - SMC3
  - Cpn
  - Capa
  - capt
  - bel
  - SERCA
  - Cadps
  - Egfr
  - Myc
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MTOR
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - SHE
  - GRB2
  - PDK1
  - PDPK1
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PTEN
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - TSC2
  - TSC1
  - CCL26
  - RHEB
  - RHEBP1
  - GSK3A
  - GSK3B
  - BAD
  - BCL2
  - EIF4EBP1
  - RPS6KB1
  - RPS6
  - EIF4E
  - CTAA1
  - LNPEP
  - SERPINB6
  - HACD1
  - CAP1
  - SORBS1
  - BRD4
  - CAP2
  - THOP1
  - LINC00273
  - TOP1
  - TOP1MT
  - TOP3A
  - TOP3B
  - TOP2A
  - TOP2B
  - MYC
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
